Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif

Immunology

Volumn 96, Issue 1, 1999, Pages 1-9

  Wymann, D ^a   Bluggel M ^b   Kalbacher, H ^c   Blesken, T ^a   Akdis, C A ^a   Meyer, H E ^b   Blaser, K ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Medizinisch Naturwissenschaftliches Forschungszentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; EPSTEIN BARR VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

ALLELES; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BINDING SITES; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 4, HUMAN; HLA-DR ANTIGENS; HUMANS; LEUKOCYTE MIGRATION-INHIBITORY FACTORS; MOLECULAR SEQUENCE DATA;

EID: 0032943666     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00652.x     Document Type: Article

References (34)

1. 1. ZIEGLER H.K. & UNANUE E.R. (1991) Identification of a macrophage antigen processing event required for I-region restricted antigen presentation to T lymphocytes. J Immunol 127, 1869.
2. 2. GERMAIN R.N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287.
3. 3. CRESSWELL P. (1992) Chemistry and functional role of the invariant chain. Curr Opin Immunol 4, 87.
4. 4. LOTTEAU V., TEYTON L., PELERAUX A. et al. (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600.
5. 5. ROCHE P.A. & CRESSWELL P. (1993) Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 88, 3150.
6. 6. BLUM J.S. & CRESSWELL P. (1988) Role of intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85, 3975.
7. 7. RUPPERT J., FRANCO A., ALEXANDER J. et al. (1995) MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression? Chem Immunol 60, 61.
8. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 In Vitro J Clin Invest 98, 1676.
9. 9. HAMMER J., BELUNIS C., BOLIN D. et al. (1994) High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci USA 91, 4456.
10. 10. HAMMER J., TAKACS B. & SINIGAGLIA F. (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176, 1007.
11. 11. FALK K., RÖTZSCHKE O., STEVANOVIC S., JUNG G. & RAMMENSEE H.-G. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290.
12. d. Science 256, 1817.
13. 13. CHICZ R.M., URBAN R.G., LANE W.S. et al. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764.
14. 14. O'SULLIVAN D., ARRHENIUS T., SIDNEY J. et al. (1991) On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol 147, 2663.
15. 15. CARBALLIDO J.M., FAITH A., CARBALLIDO-PERRIG N. & BLASER K. (1997) The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 27, 515.
16. 16. HALDER T., PAWELEC G., KIRKIN A.F. et al. (1997) Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res 57, 3238.
17. 17. FRIEDE T., GNAU V., JUNG G., KEILHOLZ W., STEVANOVIC S. & RAMMENSEE H.-G. (1996) Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim Biophys Acta 1316, 85.
18. 18. MATSUSHITA S., TAKAHASHI K., MOTOKI M., KOMORIYA K., IKAGAWA S. & NISHIMURA Y. (1994) Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: Implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180, 873.
19. 19. BOTTEL B., BLANK U., MÈGE D. et al. (1995) Strong similarities in antigen fine specificity among DRB1*1302-restricted tetanus toxin tt830-specific TCRs in spite of highly heterogeneous CDR3. J Immunol 154, 3245.
20. 20. BRUSIC V., RUDY G., KYNE A.P. & HARRISON L. (1996) MHCPEP a database of MHC-binding peptides: update 1995. Nucl Acids Res 24, 242.
21. 21. HAMMER J., VALSASNINI P., TOLBA K. et al. (1993) Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74, 197.
22. 22. FALK K., RÖTZSCHKE O., STEVANOVIC S., JUNG G. & RAMMENSEE H.-G. (1994) Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39, 230.
23. 23. SETTE A., DEMARS R., GREY H.M. et al. D.F. (1993) Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells. Chem Immunol 57, 152.
24. 24. RUDENSKY A.Y., PRESTON-HURLBURT P., HONG S.C., BARLOW A. & JANEWAY C.A. JR (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622.
25. 25. NELSON C.A., PETZOLD S.J. & UNANUE E.R. (1994) Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250.
26. 26. LARSEN S.L., PEDERSEN L.O., BUUS S. & STRYHN A. (1996) T cell response affected by aminopeptidase N (CD13) -mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 184, 183.
27. 27. BRELOER M., EHRLICH S., FLEISCHER B. & VON BONIN A. (1996) A biological function for the XP motif within the N terminus of major histocompatibility complex class II-associated peptides. Eur J Immunol 26, 1825.
28. 28. WU S., GORSKI J., ECKELS D.D. & NEWTON-NASH D.K. (1996) T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide MHC complex. J Immunol 156, 3815.
29. 29. STRYHN A., PEDERSEN L.O., ROMME T., HOLM C.B., HOLM A. & BUUS S. (1996) Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur J Immunol 26, 1911.
30. 30. BACHER M., METZ C., CALANDRA T. et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93, 7849.
31. 31. BERNHAGEN J., CALANDRA T., CERAMI A. & BUCALA R. (1994) Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia. Trends Microbiol 2, 198.
32. 32. ROCKLIN R.E., CHESS L., MACDERMOTT R.P., SCHLOSSMAN S.F. & DAVID J.R. (1975) Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. Rheumatology 6, 98.
33. 33. SUGANE K., DASAHARA T. & SHIOIRI-NAKANO K. (1975) Release of migration inhibitory factor from mouse T and B cells activated by insoluble phytomitogens. Jpn J Exp Med 45, 19.
34. 34. SANTAMARIA L.F., BHEEKHA R., VAN REIJSEN F.C. et al. (1993) Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum Immunol 37, 23.